Steven N. Knapp
General Counsel bei ANTARES PHARMA, INC.
Profil
Steven N.
Knapp is currently the Senior VP-Regulatory Affairs & Quality Assurance at Antares Pharma, Inc. and the Chief Regulatory Affairs & Quality Officer at Boaoxin Biotechnology Nanjing Co Ltd.
He previously worked as the Vice President-Regulatory Affairs at Ikaria, Inc. and as the Global Vice President-Regulatory & Quality at Bausch Health Cos., Inc. He also briefly worked as the Vice President-Global Regulatory Affairs at Endo Pharmaceuticals, Inc. Dr. Knapp received his undergraduate, graduate, and doctorate degrees from Rutgers State University of New Jersey.
Aktive Positionen von Steven N. Knapp
| Unternehmen | Position | Beginn |
|---|---|---|
| ANTARES PHARMA, INC. | General Counsel | - |
Boaoxin Biotechnology Nanjing Co Ltd.
 Boaoxin Biotechnology Nanjing Co Ltd. BiotechnologyHealth Technology Boaoxin Biotechnology Nanjing Co Ltd. is a biotechnology company that focuses on the discovery and clinical development of antibody drugs. The company is based in Nanjing, China. | General Counsel | - |
Ehemalige bekannte Positionen von Steven N. Knapp
| Unternehmen | Position | Ende |
|---|---|---|
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Corporate Officer/Principal | 01.11.2015 |
| IKARIA, INC. | Corporate Officer/Principal | - |
| BAUSCH HEALTH COMPANIES INC. | Corporate Officer/Principal | - |
Ausbildung von Steven N. Knapp
| Rutgers State University of New Jersey | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BAUSCH HEALTH COMPANIES INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
Boaoxin Biotechnology Nanjing Co Ltd.
Boaoxin Biotechnology Nanjing Co Ltd. BiotechnologyHealth Technology Boaoxin Biotechnology Nanjing Co Ltd. is a biotechnology company that focuses on the discovery and clinical development of antibody drugs. The company is based in Nanjing, China. | Health Technology |
